NCT02766985View on ClinicalTrials.gov

Rasch-analysis of Clinical Severity in FSHD

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions
Facioscapulohumeral Muscular Dystrophy
Trial Locations (2)

66160

University of Kansas Medical Center, Kansas City

84112

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Kansas Medical Center

OTHER

NCT02766985 - Rasch-analysis of Clinical Severity in FSHD | Biotech Hunter | Biotech Hunter